Does routine measurement of lipoprotein(a) in a UK lipid clinic alter management in the absence of Lp(a)-specific therapy?

Puntos clave

• To determine if routine measurement of lipoprotein(a) changes management in lipid clinics without specific therapy for Lp(a).
• Conducted Lp(a) testing in a UK lipid clinic.
• Evaluated alterations in management following test results.
• Performed cost-effectiveness modelling for one-time Lp(a) testing.
• Routine Lp(a) testing significantly alters management decisions.
• Identified residual dyslipidaemia that standard therapies do not address.
• Cost-effectiveness modelling indicates savings for the NHS and society.